Matches in Wikidata for { <http://www.wikidata.org/entity/Q88344190> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q88344190 description "article scientifique publié en 2018" @default.
- Q88344190 description "artículu científicu espublizáu n'abril de 2018" @default.
- Q88344190 description "scientific article published on 01 April 2018" @default.
- Q88344190 description "wetenschappelijk artikel" @default.
- Q88344190 description "наукова стаття, опублікована у квітні 2018" @default.
- Q88344190 name "Reply: Fondaparinux and Direct Oral Anticoagulants: Promising Anticoagulant for Management of Heparin-Induced Thrombocytopenia" @default.
- Q88344190 name "Reply: Fondaparinux and Direct Oral Anticoagulants: Promising Anticoagulant for Management of Heparin-Induced Thrombocytopenia" @default.
- Q88344190 type Item @default.
- Q88344190 label "Reply: Fondaparinux and Direct Oral Anticoagulants: Promising Anticoagulant for Management of Heparin-Induced Thrombocytopenia" @default.
- Q88344190 label "Reply: Fondaparinux and Direct Oral Anticoagulants: Promising Anticoagulant for Management of Heparin-Induced Thrombocytopenia" @default.
- Q88344190 prefLabel "Reply: Fondaparinux and Direct Oral Anticoagulants: Promising Anticoagulant for Management of Heparin-Induced Thrombocytopenia" @default.
- Q88344190 prefLabel "Reply: Fondaparinux and Direct Oral Anticoagulants: Promising Anticoagulant for Management of Heparin-Induced Thrombocytopenia" @default.
- Q88344190 P1433 Q88344190-CEEEE067-CB40-4D7B-A81B-5B7D66A81008 @default.
- Q88344190 P1476 Q88344190-7DCCE0A2-AE2E-45DA-B281-DC86E724F0D8 @default.
- Q88344190 P2093 Q88344190-373245D1-BD42-440A-B862-F5BD17D3BBCA @default.
- Q88344190 P2093 Q88344190-886C7C58-BD80-43D9-9E9A-CF208CA9089F @default.
- Q88344190 P2093 Q88344190-F6D05EFE-143E-471C-B42A-1C5E35DF9335 @default.
- Q88344190 P304 Q88344190-02B99D12-E73D-4606-8EC1-67A82AD1022C @default.
- Q88344190 P31 Q88344190-EB8D55B5-B324-4E7D-975A-E55E57E4CC32 @default.
- Q88344190 P356 Q88344190-676DD20D-750F-4D0A-A04E-8F51B7D3AC5A @default.
- Q88344190 P433 Q88344190-5A4377BA-5ECA-41FB-8A82-70C2886531AE @default.
- Q88344190 P478 Q88344190-A702B054-E316-4243-8198-57B7FBC752ED @default.
- Q88344190 P577 Q88344190-732A0AAF-472C-4A75-BECD-A5FCAD86B207 @default.
- Q88344190 P698 Q88344190-CC6F684B-54D3-4684-82A9-CCC7351629E4 @default.
- Q88344190 P921 Q88344190-5B18C762-E24A-44AF-8E12-2B5AB86CDC42 @default.
- Q88344190 P921 Q88344190-C317BDE6-8433-46BA-9D16-54BE5C9BEF8E @default.
- Q88344190 P921 Q88344190-F65E20F3-16D6-4C4E-A562-C681FBD76F97 @default.
- Q88344190 P356 J.JACC.2018.02.026 @default.
- Q88344190 P698 29650128 @default.
- Q88344190 P1433 Q2984355 @default.
- Q88344190 P1476 "Reply: Fondaparinux and Direct Oral Anticoagulants: Promising Anticoagulant for Management of Heparin-Induced Thrombocytopenia" @default.
- Q88344190 P2093 "Edelgard Lindhoff-Last" @default.
- Q88344190 P2093 "Marc Schindewolf" @default.
- Q88344190 P2093 "Norbert Banik" @default.
- Q88344190 P304 "1710-1712" @default.
- Q88344190 P31 Q13442814 @default.
- Q88344190 P356 "10.1016/J.JACC.2018.02.026" @default.
- Q88344190 P433 "15" @default.
- Q88344190 P478 "71" @default.
- Q88344190 P577 "2018-04-01T00:00:00Z" @default.
- Q88344190 P698 "29650128" @default.
- Q88344190 P921 Q1598365 @default.
- Q88344190 P921 Q215118 @default.
- Q88344190 P921 Q585285 @default.